Advantus Capital Management Cut Its Jpmorgan Chase & Co (JPM) Holding; Next Century Growth Investors Has Cut Its Aerie Pharmaceuticals (AERI) Holding

January 14, 2018 - By Richard Conner

Next Century Growth Investors Llc decreased Aerie Pharmaceuticals Inc (AERI) stake by 26.94% reported in 2017Q3 SEC filing. Next Century Growth Investors Llc sold 37,197 shares as Aerie Pharmaceuticals Inc (AERI)’s stock declined 8.47%. The Next Century Growth Investors Llc holds 100,887 shares with $4.90 million value, down from 138,084 last quarter. Aerie Pharmaceuticals Inc now has $2.15B valuation. The stock decreased 0.34% or $0.2 during the last trading session, reaching $58.6. About 211,758 shares traded. Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) has risen 180.20% since January 14, 2017 and is uptrending. It has outperformed by 163.50% the S&P500.

Advantus Capital Management Inc decreased Jpmorgan Chase & Co (JPM) stake by 1.06% reported in 2017Q3 SEC filing. Advantus Capital Management Inc sold 3,816 shares as Jpmorgan Chase & Co (JPM)’s stock declined 6.04%. The Advantus Capital Management Inc holds 354,806 shares with $33.89 million value, down from 358,622 last quarter. Jpmorgan Chase & Co now has $390.88B valuation. The stock increased 1.65% or $1.83 during the last trading session, reaching $112.67. About 18.88 million shares traded or 45.90% up from the average. JPMorgan Chase & Co. (NYSE:JPM) has risen 33.74% since January 14, 2017 and is uptrending. It has outperformed by 17.04% the S&P500.

Investors sentiment decreased to 0.91 in Q3 2017. Its down 0.28, from 1.19 in 2017Q2. It dropped, as 65 investors sold JPM shares while 767 reduced holdings. 125 funds opened positions while 635 raised stakes. 2.50 billion shares or 7.05% less from 2.69 billion shares in 2017Q2 were reported. Botty Investors Limited Company has 0.02% invested in JPMorgan Chase & Co. (NYSE:JPM) for 550 shares. Ccm Advisers Lc invested in 1.97% or 107,253 shares. South Dakota Council accumulated 755,489 shares. Stewart West Indies Trading Company accumulated 8.58% or 1.03 million shares. Janney Llc owns 275,125 shares or 1.13% of their US portfolio. Signaturefd Ltd reported 16,546 shares or 0.21% of all its holdings. Genesee Valley Trust, a New York-based fund reported 29,637 shares. Dnb Asset Management As holds 0.6% or 469,624 shares. Garde stated it has 17,013 shares or 0.32% of all its holdings. Mu Invests Co owns 0.1% invested in JPMorgan Chase & Co. (NYSE:JPM) for 1,430 shares. Veritable LP has invested 0.33% of its portfolio in JPMorgan Chase & Co. (NYSE:JPM). Primecap Mngmt Ca holds 23.35 million shares or 1.85% of its portfolio. 1.28 million were reported by Guggenheim Limited Liability Company. Tiaa Cref Investment Mgmt Ltd reported 18.24 million shares stake. Zeke Capital Advsr Ltd Com has invested 0.84% in JPMorgan Chase & Co. (NYSE:JPM).

Among 32 analysts covering JPMorgan Chase & Co (NYSE:JPM), 17 have Buy rating, 2 Sell and 13 Hold. Therefore 53% are positive. JPMorgan Chase & Co had 99 analyst reports since July 21, 2015 according to SRatingsIntel. The stock has “Buy” rating by Jefferies on Tuesday, June 6. Keefe Bruyette & Woods maintained it with “Hold” rating and $100.0 target in Tuesday, October 3 report. The firm earned “Neutral” rating on Wednesday, February 24 by Nomura. The stock has “Hold” rating by Robert W. Baird on Wednesday, September 20. The rating was upgraded by Credit Agricole to “Outperform” on Tuesday, August 25. Argus Research maintained JPMorgan Chase & Co. (NYSE:JPM) on Monday, January 18 with “Buy” rating. As per Thursday, October 12, the company rating was maintained by RBC Capital Markets. The firm earned “Hold” rating on Wednesday, October 11 by Keefe Bruyette & Woods. Robert W. Baird maintained JPMorgan Chase & Co. (NYSE:JPM) on Tuesday, January 2 with “Hold” rating. The stock of JPMorgan Chase & Co. (NYSE:JPM) earned “Outperform” rating by Bruyette & Woods” on Monday, August 17.

Advantus Capital Management Inc increased Vornado Realty Trust (NYSE:VNO) stake by 262,000 shares to 409,469 valued at $31.48 million in 2017Q3. It also upped Welltower Inc stake by 62,665 shares and now owns 485,170 shares. Crown Castle International Corp (NYSE:CCI) was raised too.

Since August 21, 2017, it had 0 insider purchases, and 2 insider sales for $1.12 million activity. $214,019 worth of stock was sold by Friedman Stacey on Wednesday, October 25.

Next Century Growth Investors Llc increased Universal Stainless & Alloy (NASDAQ:USAP) stake by 16,592 shares to 166,666 valued at $3.47M in 2017Q3. It also upped Axogen Inc (NASDAQ:AXGN) stake by 128,488 shares and now owns 656,766 shares. Willdan Group Inc (NASDAQ:WLDN) was raised too.

Among 14 analysts covering Aerie Pharmaceuticals (NASDAQ:AERI), 14 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Aerie Pharmaceuticals had 44 analyst reports since August 7, 2015 according to SRatingsIntel. The stock of Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) has “Outperform” rating given on Thursday, September 15 by RBC Capital Markets. The firm earned “Buy” rating on Monday, October 16 by Canaccord Genuity. The stock of Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) earned “Buy” rating by Cantor Fitzgerald on Thursday, September 17. The firm has “Buy” rating given on Wednesday, August 16 by Canaccord Genuity. Cantor Fitzgerald maintained the shares of AERI in report on Wednesday, October 11 with “Buy” rating. The firm earned “Outperform” rating on Wednesday, November 4 by RBC Capital Markets. The firm has “Buy” rating given on Thursday, September 15 by Stifel Nicolaus. The rating was maintained by Cantor Fitzgerald with “Buy” on Monday, December 18. The firm earned “Buy” rating on Thursday, July 20 by Cantor Fitzgerald. The rating was maintained by Cowen & Co on Thursday, November 9 with “Buy”.

Analysts await Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) to report earnings on March, 6. They expect $-1.44 EPS, down 65.52% or $0.57 from last year’s $-0.87 per share. After $-0.89 actual EPS reported by Aerie Pharmaceuticals, Inc. for the previous quarter, Wall Street now forecasts 61.80% negative EPS growth.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Market News

>